Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

98 results about "Cream base" patented technology

How to use Cream Base. Use this product as directed. Some products require priming before use. Follow all directions on the product package. If you are uncertain about any of the information ...

Citrus-derived cosmetic and medicinal composition, and nutritional food ingredient and associated methods of application

A method to encompass a citrus-based cream or gel composition that is highly stable and all-natural from components in situ by removing undesired components from citrus, producing such cream or gel with desired components and texture according to intended use, either as a cosmetic or medicinal lotion, a cream base, or as a food ingredient with nutraceutical and / or binding properties for use in as example analogue meats. The method comprises the steps of grinding whole citrus fruit or peel adjusted via rate of heating and pH to optimize gel consistency and desired residual bioflavonoids rather than maximizing pectin production. Citrus-derived components such as, but not limited to, d-limonene, naringin, and psoralen are added to and blended with the gel for applications which require concentrations higher than found in vivo.
Owner:AHRENS JASON ROBERT

Anti-acne cream based on high-purity herbal extract, and preparation method of anti-acne cream

The invention provides anti-acne cream based on high-purity herbal extract, and a preparation method of the anti-acne cream. The preparation method concretely comprises the following steps: (1) cleaning natural herbaceous plants, drying the cleaned herbaceous plants in the air, then cutting the dried herbaceous plants and grinding into powder, mixing the powder of the herbaceous plants according to proportion, adding an ethanol water solution into the mixture, carrying out ultrasonic dispersion, carrying out heat reflux extraction for twice, and carrying out rotary evaporation and concentration on filtrate until the filtrate is free from alcohol taste to obtain extract of the natural herbaceous plants; (2) centrifuging the extract of the natural herbaceous plants and taking supernatant of the extract, putting the supernatant into dry macroporous resin, standing still and carrying out suction filtration; after absorption, transferring the macroporous resin into a 80-90% of ethanol water solution, standing still and carrying out suction filtration; taking out the macroporous resin, carrying out rotary evaporation on filtrate until the filtrate is free from alcohol taste to obtain purified extract of the natural herbaceous plants; (3) mixing auxiliary agents, heating mixture up to 80-90 DEG C, stirring the heated mixture until the mixture is completely dissolved, cooling to 45-50 DEG C, adding the purified extract of the natural herbaceous plants into the mixture, evenly stirring, carrying out heat preservation, and then carrying out rotary evaporation until the mixture is in a cream state to obtain the anti-acne cream based on the high-purity herbal extract.
Owner:GUANGZHOU BAICAOTANG PHARMA

Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it

The present invention is directed to a medicinal composition for treating bacterial skin infections and related wounds, and also other skin wounds including those caused by burns. The cream also causes skin rejuvenation through an epithelisation process. The cream comprises a) a biopolymer in the form of Chitosan, b) an Active Pharmaceutical Ingredient (API), in the form of fusidic, c) a cream base, and d) water. The invention also discloses a process to make the medicinal cream in which Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material, by converting it into Fusidic acid under oxygen-free environment created using inert gas, preferably nitrogen. The cream produced by the process of the present invention has greater shelf-life stability and the finer particle size of the API than the conventional creams containing Fusidic acid and found to be surprisingly superior for use against skin infections with allergy & itching, & wounds on human skin than alternative creams currently available.
Owner:SULUR VANANGAMUDI SUBRAMANIAM +4

Traditional Chinese medicine and western medicine-combined formula for radically treating chloasma and preparation process thereof

The invention discloses a traditional Chinese medicine and western medicine-combined formula for removing chloasma at one time and a preparation process thereof. A product prepared according to the formula comprises a liquid medicine A and an ointment B, which are used respectively. The liquid medicine A is prepared from 10 to 50g of white silkworm, 10 to 50g of white poria, 10 to 50g of angelica dahurica, 10 to 50g of thunberg fritillary bulb, 10 to 20ml of bletilla, 10 to 50g of largehead atractylodes rhizome and a proper amount of 75 percent ethanol, and the liquid medicine A is prepared by the following steps of: crushing the white silkworm, the white poria, the angelica dahurica, the thunberg fritillary bulb, the bletilla and the largehead atractylodes rhizome, adding the proper amount of 75 percent ethanol, soaking for 3 to 10 days, removing dregs, and adding the 75 percent ethanol until the total volume is 1,000ml so as to obtain the liquid medicine A; and the ointment B is prepared from 0.03 to 0.1 mg of neomycin, 0.3 to 1 mg of clobetasol propionate, 5 to 15 mg of ketoconazole, a proper amount of glycerol and a proper amount of cream base, and the ointment B is prepared by the following steps of: adding the proper amount of the glycerol into the neomycin, the clobetasol propionate and the ketoconazole and grinding into paste, adding the proper amount of the cream base, and uniformly grinding to prepare the ointment B. The chloasma removing technology is that: the liquid medicine A is applied to an affected part until the chloasma basically disappears, the ointment B is applied to the affected part, and the chloasma can be cured within 20 to 50 days. The invention has a good chloasma removing effect, and ensures no recurrence and no side effect.
Owner:费小平

Medicinal cream made using silver sulphadiazine and chitosan and a process to make it

The present invention is directed to a composition for treating bacterial skin infections, along with skin rejuvenation. More particularly, the present invention relates to a pharmaceutical cream comprising a biopolymer, and an antibacterial active ingredient. It discloses a composition for treating fungal skin infections along with skin rejuvenation containing a) a biopolymer in the form of chitosan, b) an active pharmaceutical ingredient (API) composition in the form of silver sulphadiazine used in treating bacterial skin infections, c) a cream base containing primary and secondary emulsifiers, waxy materials, co-solvents, acids, preservatives, buffering agents, anti oxidants, chelating agents, and humectants and d) water. The active ingredients, namely chitosan, and an anti bacterial agent in the form of silver sulphadiazine, are incorporated in cream base for use in treating bacterial skin infections with allergy & itching, & wounds on human skin involving contacting human skin with the above identified composition.
Owner:SUBRAMANIAM VANANGAMUDI SULUR +3

Pharmaceutical preparations containing highly volatile silicones

PendingUS20140079791A1Improve stability penetration propertyImprove stabilityAntibacterial agentsBiocidePharmaceutical formulationHexamethyldisiloxane
The subject of the present invention is a transdermal preparation containing pharmaceutically active ingredient, wherein the particles of the active ingredient are coated with highly volatile silicones or a mixture thereof, and these coated particles are dispersed in a gel or cream base. The volatile silicone component is hexamethyldisiloxane and / or octamethyltrisiloxane and / or decamethylpentacyclo-siloxane. A further subject of the present invention is a method for the preparation of such pharmaceutical compositions.
Owner:EGIS PHARM PLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products